345 related articles for article (PubMed ID: 25640761)
1. Actin cytoskeletal rearrangement and dysfunction due to activation of the receptor for advanced glycation end products is inhibited by thymosin beta 4.
Kim S; Kwon J
J Physiol; 2015 Apr; 593(8):1873-86. PubMed ID: 25640761
[TBL] [Abstract][Full Text] [Related]
2. Thymosin β4 has a major role in dermal burn wound healing that involves actin cytoskeletal remodelling via heat-shock protein 70.
Kim S; Kwon J
J Tissue Eng Regen Med; 2017 Apr; 11(4):1262-1273. PubMed ID: 25921810
[TBL] [Abstract][Full Text] [Related]
3. The C-terminal tails of 4,4'-diphenylmethane-bis(methyl) carbamate are essential for binding to receptor for advanced glycation end products to attenuate advanced glycation end products-induced inflammation and apoptosis responses in human umbilical vein endothelial cells.
Feng L; Zhu MM; Bu WQ; Wang CF; Zheng ZG; Wang RS; Jia XB; Zhu Q
J Pharm Pharmacol; 2016 Jan; 68(1):93-106. PubMed ID: 26806697
[TBL] [Abstract][Full Text] [Related]
4. Glyceraldehyde-derived pyridinium (GLAP) evokes oxidative stress and inflammatory and thrombogenic reactions in endothelial cells via the interaction with RAGE.
Matsui T; Oda E; Higashimoto Y; Yamagishi S
Cardiovasc Diabetol; 2015 Jan; 14():1. PubMed ID: 25582325
[TBL] [Abstract][Full Text] [Related]
5. Glycolaldehyde-derived advanced glycation end products (glycol-AGEs)-induced vascular smooth muscle cell dysfunction is regulated by the AGES-receptor (RAGE) axis in endothelium.
Nam MH; Son WR; Lee YS; Lee KW
Cell Commun Adhes; 2015; 22(2-6):67-78. PubMed ID: 27602595
[TBL] [Abstract][Full Text] [Related]
6. Protection of glycyrrhizic acid against AGEs-induced endothelial dysfunction through inhibiting RAGE/NF-κB pathway activation in human umbilical vein endothelial cells.
Feng L; Zhu MM; Zhang MH; Wang RS; Tan XB; Song J; Ding SM; Jia XB; Hu SY
J Ethnopharmacol; 2013 Jun; 148(1):27-36. PubMed ID: 23528363
[TBL] [Abstract][Full Text] [Related]
7. Effect of thymosin beta 4 in the presence of up-regulation of the insulin-like growth factor-1 signaling pathway on high-glucose-exposed vascular endothelial cells.
Kim S; Kwon J
Mol Cell Endocrinol; 2015 Feb; 401():238-47. PubMed ID: 25540921
[TBL] [Abstract][Full Text] [Related]
8. The protective effect of Smilax glabra extract on advanced glycation end products-induced endothelial dysfunction in HUVECs via RAGE-ERK1/2-NF-κB pathway.
Sang HQ; Gu JF; Yuan JR; Zhang MH; Jia XB; Feng L
J Ethnopharmacol; 2014 Aug; 155(1):785-95. PubMed ID: 24953033
[TBL] [Abstract][Full Text] [Related]
9. Paeoniflorin protects HUVECs from AGE-BSA-induced injury via an autophagic pathway by acting on the RAGE.
Chen Y; Du X; Zhou Y; Zhang Y; Yang Y; Liu Z; Liu C; Xie Y
Int J Clin Exp Pathol; 2015; 8(1):53-62. PubMed ID: 25755692
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of advanced glycation end products-induced hyperpermeability in endothelial cells].
Guo XH; Huang QB; Chen B; Wang SY; Hou FF; Fu N
Sheng Li Xue Bao; 2005 Apr; 57(2):205-10. PubMed ID: 15830106
[TBL] [Abstract][Full Text] [Related]
11. G-actin sequestering protein thymosin-β4 regulates the activity of myocardin-related transcription factor.
Morita T; Hayashi K
Biochem Biophys Res Commun; 2013 Aug; 437(3):331-5. PubMed ID: 23811404
[TBL] [Abstract][Full Text] [Related]
12. Effect of PKC-β Signaling Pathway on Expression of MCP-1 and VCAM-1 in Different Cell Models in Response to Advanced Glycation End Products (AGEs).
Rempel LC; Finco AB; Maciel RA; Bosquetti B; Alvarenga LM; Souza WM; Pecoits-Filho R; Stinghen AE
Toxins (Basel); 2015 May; 7(5):1722-37. PubMed ID: 26008233
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of compound 4,4'-diphenylmethane-bis(methyl)carbamate on high mobility group box1-mediated inflammation and oxidant stress responses in human umbilical vein endothelial cells via RAGE/ERK1/2/NF-κB pathway.
Feng L; Zhu M; Zhang M; Jia X; Cheng X; Ding S; Zhu Q
Int Immunopharmacol; 2013 Feb; 15(2):206-16. PubMed ID: 23219582
[TBL] [Abstract][Full Text] [Related]
14. Fructose causes endothelial cell damage via activation of advanced glycation end products-receptor system.
Sotokawauchi A; Matsui T; Higashimoto Y; Yamagishi SI
Diab Vasc Dis Res; 2019 Nov; 16(6):556-561. PubMed ID: 31375034
[TBL] [Abstract][Full Text] [Related]
15. Thymosin beta 4 attenuates PrP(106-126)-induced human brain endothelial cells dysfunction.
Song K; Han HJ; Kim S; Kwon J
Eur J Pharmacol; 2020 Feb; 869():172891. PubMed ID: 31877278
[TBL] [Abstract][Full Text] [Related]
16. Mdia1 is Crucial for Advanced Glycation End Product-Induced Endothelial Hyperpermeability.
Zhou X; Weng J; Xu J; Xu Q; Wang W; Zhang W; Huang Q; Guo X
Cell Physiol Biochem; 2018; 45(4):1717-1730. PubMed ID: 29490301
[TBL] [Abstract][Full Text] [Related]
17. Co-ordinate regulation of the cytoskeleton in 3T3 cells overexpressing thymosin-beta4.
Golla R; Philp N; Safer D; Chintapalli J; Hoffman R; Collins L; Nachmias VT
Cell Motil Cytoskeleton; 1997; 38(2):187-200. PubMed ID: 9331222
[TBL] [Abstract][Full Text] [Related]
18. Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells.
Higashimoto Y; Matsui T; Nishino Y; Taira J; Inoue H; Takeuchi M; Yamagishi S
Microvasc Res; 2013 Nov; 90():64-70. PubMed ID: 24012635
[TBL] [Abstract][Full Text] [Related]
19. Glucose-dependent insulinotropic polypeptide (GIP) inhibits signaling pathways of advanced glycation end products (AGEs) in endothelial cells via its antioxidative properties.
Ojima A; Matsui T; Maeda S; Takeuchi M; Yamagishi S
Horm Metab Res; 2012 Jun; 44(7):501-5. PubMed ID: 22581648
[TBL] [Abstract][Full Text] [Related]
20. Receptor for advanced glycation end products (RAGE) prevents endothelial cell membrane resealing and regulates F-actin remodeling in a beta-catenin-dependent manner.
Xiong F; Leonov S; Howard AC; Xiong S; Zhang B; Mei L; McNeil P; Simon S; Xiong WC
J Biol Chem; 2011 Oct; 286(40):35061-70. PubMed ID: 21844192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
